Photos and Logos
Cologuard analyzes both DNA alterations and blood in the stool to detect the presence of colon cancer and precancers. With Cologuard, patients can provide a sample in the privacy of their own home.
Cologuard is the first FDA-approved, noninvasive, stool-based DNA (sDNA) colorectal cancer screening test. Cologuard is intended for men and women 50 years or older at average risk for colorectal cancer.
